Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load.
about
A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype JNew enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNAHepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain.Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis BMutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversionSerum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxisHepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients.Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assayHBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b.Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.New perspectives of biomarkers for the management of chronic hepatitis B.Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B.Safe and cost-effective control of post-transplantation recurrence of hepatitis B.Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analogue treatment.Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication.Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.Serum HBV core-related antigen is a good predictor for spontaneous HBeAg seroconversion in chronic hepatitis B patients.The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.Diagnosis of Herpes Simplex Encephalitis by ELISA Using Antipeptide Antibodies Against Type-Common Epitopes of Glycoprotein B of Herpes Simplex Viruses.Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B.Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.JSH Guidelines for the Management of Hepatitis B Virus Infection.Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B.Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.Characteristics and prediction of hepatitis B e-antigen negative hepatitis following seroconversion in patients with chronic hepatitis B.Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.Serum HBV RNA as a possible marker of HBV replication in the liver during nucleot(s)ide analogue therapy.Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance.Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B.Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection.Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.
P2860
Q24646080-BC9CC045-F8A3-403E-9950-2A93C180909BQ24675792-B6F53612-8F83-4CAE-ADF1-733FD0B7FF5BQ31158133-8E419B8C-73F8-493D-9920-1EDC817B1569Q33669333-306ED889-9D5B-4104-8B1C-BBD749D4FB2FQ34932600-D273D6B7-9378-493C-8AA4-B2A7FCD84179Q35549423-CB9746C3-6BBD-4E6F-ABA1-DB4C09863E0DQ36314552-49AC5EC9-562C-4036-BA4B-8FEEA11C85ACQ36351904-02EBB362-C77B-4FF7-8CEF-D2E4A8B0293CQ36971054-4B98DA7F-CDA9-48F5-AAED-5273EA89B13AQ37135543-F2491282-8B42-477D-A046-F9A934D2E7CFQ37255017-3FF0E705-E70B-4C1E-90C1-D3FEC9CAA9CFQ37470263-7B586238-DE94-44A5-9582-809CB20B650DQ37606546-431E01D2-13CB-4352-8DC8-193F3C5BF2E7Q37727852-8391C99A-61B8-47FD-8746-58FA6A2F7D89Q38100847-4B3F5E18-88A9-4C5B-B429-72CA6444F04FQ38218260-D73B60A8-97F7-4424-A8B7-282B01F51CFBQ38596871-E4281606-2B66-4E91-9D52-ACC59834DA10Q38815530-5930C73C-CC4A-4C01-9658-511C499682C5Q39558394-F151EED2-1B48-464D-BCEF-16D2A30BF70BQ39590608-81C11964-96D6-40E5-B3D0-78E6FAD94592Q40151821-DBA03D83-EDE9-43CF-BFE9-21D874558BD3Q40582667-2FF87F6F-4BFD-451B-98E2-00CEE5BA3D24Q40611613-3C411EA3-EDDD-4FA8-9031-F94E83F4A37BQ40898129-82C4D713-A19D-4632-B5BF-EC6ACAB0FC82Q41042019-B0F1318E-F6D6-4D81-B21C-0EB955E1FDCFQ41791106-A4F2CE72-8BC4-4D1E-8278-782CE3BC7568Q42174830-61D153F1-E72F-4AE4-BE16-7068E35863F7Q42244740-E81E1338-2561-48FA-8D42-4C84D95D92F2Q42250951-3073EAEC-FBAA-46B1-A682-FC258CEBD1D9Q42262670-23EB2B17-A768-4B07-9107-B1178236310BQ42283787-5E75FD1C-CAB5-4A3B-B727-E1DE4D5AC416Q42525426-EDCBB975-6A95-403D-B8F5-284B2BAA51E6Q43551860-1FEF803D-E3DE-4E72-8D0D-D7A5AF8CCFB4Q43569399-F6FCC3BA-E7E9-4020-9823-F78EDBB81D3BQ43950558-603D990F-46E0-406C-BB48-D196796F0EB0Q43975290-11E9A955-0650-4199-B053-39005BD890FAQ44082487-F92DDC3A-7200-4A6C-A2F3-4B3DDA9FBCDEQ44329278-BE17B410-F2F0-429C-A715-4192C6DB41F9Q44489304-43D70191-9AD9-4D5D-B3C8-DB82A5493300Q45326295-0F77DA61-7702-47F4-BF90-188F0B7244BF
P2860
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Sensitive enzyme immunoassay f ...... eir correlation to virus load.
@en
Sensitive enzyme immunoassay f ...... eir correlation to virus load.
@nl
type
label
Sensitive enzyme immunoassay f ...... eir correlation to virus load.
@en
Sensitive enzyme immunoassay f ...... eir correlation to virus load.
@nl
prefLabel
Sensitive enzyme immunoassay f ...... eir correlation to virus load.
@en
Sensitive enzyme immunoassay f ...... eir correlation to virus load.
@nl
P2093
P2860
P1476
Sensitive enzyme immunoassay f ...... eir correlation to virus load.
@en
P2093
Akinori Rokuhara
Eiji Tanaka
Kendo Kiyosawa
Noboru Maki
Shintaro Yagi
Tatsuji Kimura
Yoko Sakamoto
P2860
P304
P356
10.1128/JCM.40.2.439-445.2002
P407
P577
2002-02-01T00:00:00Z